» Articles » PMID: 36396937

Stereoisomeric Engineering of Aggregation-induced Emission Photosensitizers Towards Fungal Killing

Overview
Journal Nat Commun
Specialty Biology
Date 2022 Nov 17
PMID 36396937
Authors
Affiliations
Soon will be listed here.
Abstract

Fungal infection poses and increased risk to human health. Photodynamic therapy (PDT) as an alternative antifungal approach garners much interest due to its minimal side effects and negligible antifungal drug resistance. Herein, we develop stereoisomeric photosensitizers ((Z)- and (E)-TPE-EPy) by harnessing different spatial configurations of one molecule. They possess aggregation-induced emission characteristics and ROS, viz. O and O generation capabilities that enable image-guided PDT. Also, the cationization of the photosensitizers realizes the targeting of fungal mitochondria for antifungal PDT killing. Particularly, stereoisomeric engineering assisted by supramolecular assembly leads to enhanced fluorescence intensity and ROS generation efficiency of the stereoisomers due to the excited state energy flow from nonradiative decay to the fluorescence pathway and intersystem (ISC) process. As a result, the supramolecular assemblies based on (Z)- and (E)-TPE-EPy show dramatically lowered dark toxicity without sacrificing their significant phototoxicity in the photodynamic antifungal experiments. This study is a demonstration of stereoisomeric engineering of aggregation-induced emission photosensitizers based on (Z)- and (E)-configurations.

Citing Articles

Aggregation control of anionic pentamethine cyanine enabling excitation wavelength selective NIR-II fluorescence imaging-guided photodynamic therapy.

Li Y, Qu F, Wan F, Zhong C, Rao J, Liu Y Nat Commun. 2025; 16(1):762.

PMID: 39824804 PMC: 11748625. DOI: 10.1038/s41467-024-55429-x.


Blue light-activated 5,10,15,20-tetrakis(4-bromophenyl)porphyrin for photodynamic eradication of drug-resistant .

Qin H, Niu H, Guo Y, Wang X, Liu T, Zhao C RSC Adv. 2024; 14(53):39779-39786.

PMID: 39697839 PMC: 11653106. DOI: 10.1039/d4ra07666d.


β-Ketoenamine covalent organic framework nanoplatform combined with immune checkpoint blockade via photodynamic immunotherapy inhibit glioblastoma progression.

Yan T, Liao Q, Chen Z, Xu Y, Zhu W, Hu P Bioact Mater. 2024; 44:531-543.

PMID: 39584065 PMC: 11583667. DOI: 10.1016/j.bioactmat.2024.10.029.


Ligand-controlled regiodivergent arylation of aryl(alkyl)alkynes and asymmetric synthesis of axially chiral 9-alkylidene-9,10-dihydroanthracenes.

Sun C, Qi T, Rahman F, Hayashi T, Ming J Nat Commun. 2024; 15(1):9307.

PMID: 39468097 PMC: 11519556. DOI: 10.1038/s41467-024-53767-4.


Nanocatalytic medicine enabled next-generation therapeutics for bacterial infections.

Ge M, Jiang F, Lin H Mater Today Bio. 2024; 29:101255.

PMID: 39381264 PMC: 11459013. DOI: 10.1016/j.mtbio.2024.101255.


References
1.
Zhang L, Yan K, Zhang Y, Huang R, Bian J, Zheng C . High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proc Natl Acad Sci U S A. 2007; 104(11):4606-11. PMC: 1838648. DOI: 10.1073/pnas.0609370104. View

2.
Peng H, Liu B, Liu J, Wei P, Zhang H, Han T . "Seeing" and Controlling Photoisomerization by ()-/()-Isomers with Aggregation-Induced Emission Characteristics. ACS Nano. 2019; 13(10):12120-12126. DOI: 10.1021/acsnano.9b06578. View

3.
Li Q, Li Y, Min T, Gong J, Du L, Lee Phillips D . Time-Dependent Photodynamic Therapy for Multiple Targets: A Highly Efficient AIE-Active Photosensitizer for Selective Bacterial Elimination and Cancer Cell Ablation. Angew Chem Int Ed Engl. 2019; 59(24):9470-9477. DOI: 10.1002/anie.201909706. View

4.
Kong H, Segre J . Cultivating fungal research. Science. 2020; 368(6489):365-366. PMC: 10506662. DOI: 10.1126/science.aaz8086. View

5.
Huang Z, Chen X, ONeill S, Wu G, Whitaker D, Li J . Highly compressible glass-like supramolecular polymer networks. Nat Mater. 2021; 21(1):103-109. DOI: 10.1038/s41563-021-01124-x. View